The introduction of robot-assisted surgical technology into urological practice, has introduced new horizons for reducing the morbidity and enhancing the efficacy of surgery. Open radical cystectomy was the gold standard however over the years robot-assisted radical cystectomy has proven improved perioperative morbidity and similar oncologic outcomes. We investigate the status of RARC in 2019